Xtant Medical Holdings Inc (XTNT)
XASE:XTNT
Want to see XTNT full AI Analyst Report?
Total Valuation
Xtant Medical Holdings has a market cap or net worth of $71.38M. The enterprise value is $85.07M.
Market Cap$71.38M
Enterprise Value$85.07M
Share Statistics
Xtant Medical Holdings has 140,068,250 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding140,068,250
Owned by Insiders9.71%
Owned by Institutions0.08%
Financial Efficiency
Xtant Medical Holdings’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.49%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.49%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee617.18K
Profits Per Employee22.92K
Employee Count217
Asset Turnover1.42
Inventory Turnover1.64
Valuation Ratios
The current PE Ratio of Xtant Medical Holdings is 480.8. Xtant Medical Holdings’s PEG ratio is -0.16.
PE Ratio480.8
PS Ratio0.82
PB Ratio2.15
Price to Fair Value2.15
Price to FCF10.76
Price to Operating Cash Flow5.84
PEG Ratio-0.16
Income Statement
In the last 12 months, Xtant Medical Holdings had revenue of 133.93M and earned 4.97M in profits. Earnings per share was 0.04.
Revenue133.93M
Gross Profit84.27M
Operating Income7.28M
Pretax Income7.00M
Net Income4.97M
EBITDA15.89M
Earnings Per Share (EPS)0.04
Cash Flow
In the last 12 months, operating cash flow was 12.55M and capital expenditures -2.38M, giving a free cash flow of 10.16M billion.
Operating Cash Flow12.55M
Free Cash Flow10.16M
Free Cash Flow per Share0.07
Dividends & Yields
Xtant Medical Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.02
52-Week Price Change2.75%
50-Day Moving Average0.56
200-Day Moving Average0.65
Relative Strength Index (RSI)38.13
Average Volume (3m)163.16K
Important Dates
Xtant Medical Holdings upcoming earnings date is Apr 30, 2026, After Close (Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
Xtant Medical Holdings as a current ratio of 2.65, with Debt / Equity ratio of 56.36%
Current Ratio2.65
Quick Ratio1.63
Debt to Market Cap0.23
Net Debt to EBITDA0.73
Interest Coverage Ratio1.98
Taxes
In the past 12 months, Xtant Medical Holdings has paid 2.03M in taxes.
Income Tax2.03M
Effective Tax Rate0.29
Enterprise Valuation
Xtant Medical Holdings EV to EBITDA ratio is 7.62, with an EV/FCF ratio of 11.91.
EV to Sales0.90
EV to EBITDA7.62
EV to Free Cash Flow11.91
EV to Operating Cash Flow9.65
Balance Sheet
Xtant Medical Holdings has $17.05M in cash and marketable securities with $28.72M in debt, giving a net cash position of -$11.66M billion.
Cash & Marketable Securities$17.05M
Total Debt$28.72M
Net Cash-$11.66M
Net Cash Per Share-$0.08
Tangible Book Value Per Share$0.32
Margins
Gross margin is 62.92%, with operating margin of 5.44%, and net profit margin of 3.71%.
Gross Margin62.92%
Operating Margin5.44%
Pretax Margin5.23%
Net Profit Margin3.71%
EBITDA Margin11.87%
EBIT Margin7.97%
Analyst Forecast
The average price target for Xtant Medical Holdings is $1.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$1.25
Price Target Upside145.10% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast16.88%
EPS Growth Forecast―